New pill cuts “bad” cholesterol by 60% in major trial

A new experimental pill called enlicitide dramatically lowered levels of low-density lipoprotein (LDL) cholesterol, often referred to as "bad" cholesterol, by as much as 60%, according to a phase three clinical trial published in The New England Journal of Medicine. If the drug receives approval from the Food and Drug Administration, it could offer millions of people in the United States a new way to reduce their risk of heart attacks and strokes.

1. Homepage
2. Science
3. New pill cuts “bad” cholesterol by 60% in major trial